Doyon; Julien Georges Pierre-Olivier

Patent Applications and Registrations

Patent applications and USPTO patent grants for Doyon; Julien Georges Pierre-Olivier.The latest application filed is for "novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders".

Company Profile

3.9.12

Doyon; Julien Georges Pierre-Olivier - Beerse BE
DOYON; Julien Georges Pierre-Olivier - US
Doyon; Julien Georges Pierre-Olivier - Turnhout BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Grant 10,568,879 - Menet , et al. Feb	2020-02-25
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors Grant 10,508,111 - Brys , et al. Dec	2019-12-17
Novel Dihydropyridoisoquinolinones And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders App 20190062325 - MENET; Christel Jeanne Marie ; et al.	2019-02-28
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-b]pyridin-3-yl]-nicotinonitrile Derivatives And Their Use As Irak Inhibitors App 20180305351 - BRYS; Reginald Christophe Xavier ; et al.	2018-10-25
Novel Compounds Useful For The Treatment Of Bacterial Infectious Diseases App 20160297830 - DUDFIELD; Philip John ; et al.	2016-10-13
Benzocycloheptane and benzoxepine derivatives Grant 9,040,725 - Schoentjes , et al. May 26, 2	2015-05-26
Benzocycloheptane And Benzoxepine Derivatives App 20140187557 - Schoentjes; Bruno ; et al.	2014-07-03
Benzocycloheptane and benzoxepine derivatives Grant 8,703,973 - Schoentjes , et al. April 22, 2	2014-04-22
Benzocycloheptane And Benzoxepine Derivatives App 20120322796 - SCHOENTJES; Bruno ; et al.	2012-12-20
Benzocycloheptane and benzoxepine derivatives Grant 8,278,466 - Schoentjes , et al. October 2, 2	2012-10-02
Benzocycloheptane And Benzoxepine Derivatives App 20110046139 - Schoentjes; Bruno ; et al.	2011-02-24
2-amino-4,5-trisubstituted thiazolyl derivatives Grant 7,803,823 - Love , et al. September 28, 2	2010-09-28
Mercaptoimidazoles As Ccr2 Receptor Antagonists App 20090192206 - VAN LOMMEN; Guy Rosalia Eugeen ; et al.	2009-07-30
Mercaptoimidazoles as CCR2 receptor antagonists Grant 7,511,068 - Van Lommen , et al. March 31, 2	2009-03-31
Mercaptoimidazoles as Ccr2 Receptor Antagonists App 20070249691 - Boeckx; Gustaaf Maria ; et al.	2007-10-25
Mercaptoimidazoles as Ccr2 Receptor Antagonists App 20070244138 - Boeckx; Gustaaf Maria ; et al.	2007-10-18
2-Amino-4,5-Trisubstituted Thiazolyl Derivatives App 20070203189 - Love; Christopher John ; et al.	2007-08-30
2-amino-4,5-trisubstituted thiazolyl derivatives Grant 7,232,838 - Love , et al. June 19, 2	2007-06-19
Mercaptoimidazoles as ccr2 receptor antagonists App 20060058289 - Van Lommen; Guy Rosalia Eugeen ; et al.	2006-03-16
2-amino-4,5-trisubstituted thiazolyl derivatives App 20040254191 - Love, Christopher John ; et al.	2004-12-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.